NCT00999128View on ClinicalTrials.gov

A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 26, 2009

Primary Completion Date

February 26, 2010

Study Completion Date

February 26, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

GDC-0941

Oral repeating dose

DRUG

rabeprazole

Oral repeating dose

Trial Locations (1)

94080

Genentech Trial Information Support, South San Francisco

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY